We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment Use of 3,4-Diaminopyridine

Expanded access is currently available for this treatment.
Verified January 2017 by Vern C. Juel, M.D., Duke University Medical Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT01765140
First Posted: January 10, 2013
Last Update Posted: January 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Vern C. Juel, M.D., Duke University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Study Completion Date: No date given
  Primary Completion Date: No date given